Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CRISPR-Cas9 protein (NLS)

Origine: Streptococcus aureus Hôte: Escherichia coli (E. coli) Recombinant GEEN
N° du produit ABIN7509364
  • Antigène
    CRISPR-Cas9
    Type de proteíne
    Recombinant
    Origine
    Streptococcus aureus
    Source
    • 6
    Escherichia coli (E. coli)
    Purification/Conjugué
    NLS
    Application
    Genome Editing with Engineered Nucleases (GEEN)
    Fonction
    SaCas9 2NLS Nuclease
    Attributs du produit
    Recombinant Streptococcus aureus tag-free Cas9 nuclease expressed in an Escherichia coli with both N-terminal and C-terminal nucleic localization signal (NLS).
    Purification
    Escherichia coli expression system
    niveau d'endotoxine
    10 EU/mg as analyzed by gel clotting method
  • Indications d'application
    CRISPR Genomic editing
    The optimal working dilution should be determined by the end user.
    Procédure de l'essai

    Cleavage assay: A 20 uL reaction in 1xSaCas9 Nuclease Reaction Buffer containing linearized plasmid, gRNA, and SaCas9 2NLS Nuclease for 2 hours at 37°C results in a digestion efficiency of linearized plasmid higher than 90%, as determined by agarose gel electrophoresis.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    In 20 mM Tris, 300 mM NaCl, 0.1 mM TCEP, pH 7.5 (50 % glycerol).
    Stock
    -20 °C
  • Antigène
    CRISPR-Cas9
    Autre désignation
    Cas9 nuclease
Vous êtes ici: